Compare LQDA & MWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | MWH |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.1B |
| IPO Year | 2020 | 2026 |
| Metric | LQDA | MWH |
|---|---|---|
| Price | $68.49 | $25.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $41.00 | $35.42 |
| AVG Volume (30 Days) | 963.9K | ★ 1.2M |
| Earning Date | 05-08-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.81 | N/A |
| EPS | ★ 1.26 | 0.11 |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $278.87 | $51.86 |
| Revenue Next Year | $57.13 | $14.78 |
| P/E Ratio | ★ $56.31 | $227.73 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $21.35 | $23.83 |
| 52 Week High | $93.61 | $48.40 |
| Indicator | LQDA | MWH |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 41.83 |
| Support Level | $62.86 | $23.88 |
| Resistance Level | $92.35 | $30.74 |
| Average True Range (ATR) | 2.78 | 1.18 |
| MACD | 0.69 | 0.10 |
| Stochastic Oscillator | 66.74 | 26.00 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.